Nicox
Ophthalmic drug developer focused on glaucoma and eye allergy treatments, with products sold in the U.S. and China
Highlights
- New on EvolcAdded 2026-11-02
About Nicox
Nicox is an international ophthalmology company developing therapeutics to help maintain vision and improve ocular health. Its lead pipeline program, NCX 470, has completed Phase 3 development for glaucoma in the U.S. and China, with a separate Phase 3 program ongoing in Japan.
The company has two commercialized products in the U.S.: VYZULTA (latanoprostene bunod ophthalmic solution) 0.024% for open-angle glaucoma and ZERVIATE (cetirizine ophthalmic solution) 0.24% for ocular allergic conjunctivitis. ZERVIATE is also commercialized in China. Nicox has built partnerships with Pfizer, Bausch + Lomb, VISUfarma and Ocumension Therapeutics.
Nicox was founded in 1996 and is headquartered in Biot, France. Its NCX 470 NDAs were submitted to the U.S. FDA in June 2026 and to China's Center for Drug Evaluation in August 2026, with the China filing accepted for review in September 2026.
Product: VYZULTA (latanoprostene bunod) 0.024% for open-angle glaucoma and ZERVIATE (cetirizine) 0.24% for ocular allergic conjunctivitis; NCX 470 in development.
Jobs at Nicox
Leadership
- Gavin Spencer · Chief Executive OfficerSource: company website
More biotech & pharma companies
Nikaia Pharmaceuticals
Develops small-molecule NIK inhibitors for cancer and autoimmune disease treatmentYoung companyNew on EvolcNoraker
Develops and manufactures resorbable biomaterial implants for surgeons treating bone defects and supporting bone regenerationNew on EvolcNordic Pharma
Specialty pharmaceutical company marketing licensed prescription products to doctors and patients in FranceNew on EvolcNorgine
Pharmaceutical products and European commercialization partnerships for patients and healthcare systemsNew on EvolcNovalix
Preclinical drug discovery services for biotechnology and pharmaceutical companiesNew on EvolcNovaptech
Custom aptamer development, assays and biosensors for biotechnology, pharmaceutical, academic and agri-food organizationsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Gravity FormsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.